Successful treatment of renovascular hypertension has no effect on insulin sensitivity

European Journal of Clinical Investigation

Volumn 33, Issue 10, 2003, Pages 848-854

  Voiculescu, Adina ^a   Hollenbeck, M ^a   Kutkuhn, B ^a   Grabensee, B ^a   Plum, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Glucose effectiveness; Glucose metabolism; Insulin resistance; Renal artery stenosis; Renovascular hypertension; Vasoactive hormones

Indexed keywords

ADRENALIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CREATININE; CYCLIC GMP; GLUCOSE; INSULIN; NORADRENALIN; RENIN;

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MALE; MEASUREMENT; PARAMETER; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SAMPLING; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; TIME; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION, RENOVASCULAR; INSULIN RESISTANCE; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION;

EID: 0141482065     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01236.x     Document Type: Article

References (34)

1. Defronzo RA, Smith D, Alvestrand A. Insulin action in uraemia. Kidney Int Suppl 1983;16:S102-14.
2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
3. Reaven G. Role of insulin resistance in human disease. Banting Lecture. Diabetes 1988;37:1595-607.
4. Nestler JE, Mcclanahan MA. Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992;6:829-47.
5. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992;20 (Suppl. 8):S40-8.
6. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
7. Scherrer U, Sartori C. Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000;142:315-23.
8. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G. Pacifico: Insulinemia and blood pressure. Relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am J Hypertens 1990;3:521-6.
9. Shamiss A, Carroll J, Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens 1992;5:26-8.
10. Natali A, Quinones Galvan A, Arzilli F, Taddei S, Pecori N, Frascerra S et al. Renovascular hypertension and insulin sensitivity. Eur J Clin Invest 1996;26:556-63.
11. Bergmann RN, Prager R, Volund A, Olevsky MJ. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
12. Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003;52:244-51.
13. Pacini G, Bergman RN, Minmod. A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-22.
14. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993;42:250-6.
15. Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Granbensee B. Intraindividual comparison of ANP, cGMP and ölasma catecholamines between HD and CAPD. Adv Peritoneal Dial 1990;6:211-9.
16. Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under various conditions of Volume homeostasis. J Int Med 1991;229:209-16.
17. Shen DC, Shieh SM, Fuh MM. Wu DA, Chen YD, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988;66:580-3.
18. Landsberg L, Young JB. Diet and sympathetic nervous system: relationships to hypertension. Int J Obes 1981;5:79-81.
19. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings: healthy subjects Diabetologia 1992;35:873-9.
20. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest 1991;87:2246-52.
21. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992;19:621-7.
22. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone. Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997;96:4104-13.
23. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996;9:746-52.
24. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 1993;21:129-35.
25. Bursztyn M, Ben-Ishay D, Gutman A. Insulin resistance in spontaneously hypertensive rats but not in deoxycorticosterone-salt or renal vascular hypertension. J Hypertens 1992;10:137-42.
26. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 1996;98:1195-209.
27. Kutkuhn B, Hollenbeck M, Heering P, Koch M, Voiculescu A et al. Development of Insulin resistance and elevated blood pressure during therapy with Cyclosporine A. Blood Pressure 1997;6:13-7.
28. Paolisso G, Gambardella A, Galerano D, Varricchio M. Insulin resistance and hypertension in the elderly. Optimal drug therapy. Drugs Aging 1994;4:403-9.
29. Scherrer U, Sartori C. Defective nictric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000;142:315-23.
30. Lind L, Reneland R, Andersson PE, Haenni A, Lithell H. Insulin resistance in essential hypertension is related to plasma renin activity. J Hum Hypertens 1998;12:379-82.
31. Vettor R, Cusin I, Ganten D, Rohner-Jeanrenaud F, Ferrannini E, Jeanrenaud B. Insulin resistance and hypertension: studies in transgenic hypertensive TGR (mREN-2) 27 rats. Am J Physiol 1994;267:R1503-9.
32. Sindelka G, Widimsky J, Haas T, Prazny M, Hilgertova J, Skrha J. Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000;108:21-5.
33. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999;18:2537-42.
34. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001;104:342-5.